Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy

Journal of Medicinal Chemistry

Volumn 53, Issue 11, 2010, Pages 4441-4449

  Matsubara, Teruhiko ^a   Onishi, Ai ^a   Saito, Tomomi ^a   Shimada, Aki ^a   Inoue, Hiroki ^b   Taki, Takao ^c   Nagata, Kyosuke ^d   Okahata, Yoshio ^b   Sato, Toshinori ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEMAGGLUTININ; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; SIALIC ACID; SIALOGLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL SURFACE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; HOST CELL; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOLECULAR DOCKING; MOLECULAR RECOGNITION; NONHUMAN; PHAGE DISPLAY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CONSERVED SEQUENCE; DOGS; DRUG EVALUATION, PRECLINICAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; N-ACETYLNEURAMINIC ACID; PEPTIDES; SMALL MOLECULE LIBRARIES; VIRUS INTERNALIZATION;

EID: 77953213950     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1002183     Document Type: Article

References (38)

1. Hilleman, M. R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control Vaccine 2002, 20, 3068-3087
2. Suzuki, Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses Biol. Pharm. Bull. 2005, 28, 399-408
3. Colman, P. M. A novel approach to antiviral therapy for influenza J. Antimicrob. Chemother. 1999, 44 (Suppl B) 17-22
4. Ward, P.; Small, I.; Smith, J.; Suter, P.; Dutkowski, R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic J. Antimicrob. Chemother. 2005, 55 (Suppl 1) i5-i21
5. von Itzstein, M.; Wu, W. Y.; Kok, G. B.; Pegg, M. S.; Dyason, J. C.; Jin, B.; Van Phan, T.; Smythe, M. L.; White, H. F.; Oliver, S. W. Rational design of potent sialidase-based inhibitors of influenza virus replication Nature 1993, 363, 418-423
6. Hay, A. J.; Wolstenholme, A. J.; Skehel, J. J.; Smith, M. H. The molecular basis of the specific anti-influenza action of amantadine EMBO J. 1985, 4, 3021-3024
7. Collins, P. J.; Haire, L. F.; Lin, Y. P.; Liu, J.; Russell, R. J.; Walker, P. A.; Skehel, J. J.; Martin, S. R.; Hay, A. J.; Gamblin, S. J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008, 453, 1258-1261, Epub 2008 May 1214.
8. Luscher-Mattli, M. Influenza chemotherapy: a review of the present state of art and of new drugs in development Arch. Virol. 2000, 145, 2233-2248
9. Wiley, D. C.; Skehel, J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu. Rev. Biochem. 1987, 56, 365-394
10. Guo, C. T.; Sun, X. L.; Kanie, O.; Shortridge, K. F.; Suzuki, T.; Miyamoto, D.; Hidari, K. I.; Wong, C. H.; Suzuki, Y. An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses Glycobiology 2002, 12, 183-190
11. Matrosovich, M.; Klenk, H. D. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding Rev. Med. Virol. 2003, 13, 85-97
12. Reuter, J. D.; Myc, A.; Hayes, M. M.; Gan, Z.; Roy, R.; Qin, D.; Yin, R.; Piehler, L. T.; Esfand, R.; Tomalia, D. A.; Baker, J. R., Jr. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers Bioconjugate Chem. 1999, 10, 271-278
13. Landers, J. J.; Cao, Z.; Lee, I.; Piehler, L. T.; Myc, P. P.; Myc, A.; Hamouda, T.; Galecki, A. T.; Baker, J. R., Jr. Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers J. Infect. Dis. 2002, 186, 1222-1230
14. Totani, K.; Kubota, T.; Kuroda, T.; Murata, T.; Hidari, K. I. P. J.; Suzuki, T.; Suzuki, Y.; Kobayashi, K.; Ashida, H.; Yamamoto, K.; Usui, T. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(l-glutamic acid) backbone for inhibition of infection by influenza viruses Glycobiology 2003, 13, 315-326
15. Ogata, M.; Murata, T.; Murakami, K.; Suzuki, T.; Hidari, K. I.; Suzuki, Y.; Usui, T. Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses Bioorg. Med. Chem. 2007, 15, 1383-1393
16. Tsuchida, A.; Kobayashi, K.; Matsubara, N.; Muramatsu, T.; Suzuki, T.; Suzuki, Y. Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus Glycoconjugate J. 1998, 15, 1047-1054
17. Lees, W. J.; Spaltenstein, A.; Kingery-Wood, J. E.; Whitesides, G. M. Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A virus: multivalency and steric stabilization of particulate biological systems J. Med. Chem. 1994, 37, 3419-3433
18. Mammen, M.; Dahmann, G.; Whitesides, G. M. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition J. Med. Chem. 1995, 38, 4179-4190
19. Matsubara, T.; Sumi, M.; Kubota, H.; Taki, T.; Okahata, Y.; Sato, T. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library J. Med. Chem. 2009, 52, 4247-4256
20. Hsu, S. M.; Raine, L.; Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J. Histochem. Cytochem. 1981, 29, 577-580
21. Nakazawa, M.; Kadowaki, S. E.; Watanabe, I.; Kadowaki, Y.; Takei, M.; Fukuda, H. PA subunit of RNA polymerase as a promising target for anti-influenza virus agents Antiviral Res. 2008, 78, 194-201
22. Venkatachalam, C. M.; Jiang, X.; Oldfield, T.; Waldman, M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites J. Mol. Graph. Model. 2003, 21, 289-307
23. Kontoyianni, M.; McClellan, L. M.; Sokol, G. S. Evaluation of docking performance: comparative data on docking algorithms J. Med. Chem. 2004, 47, 558-565
24. Sauter, N. K.; Bednarski, M. D.; Wurzburg, B. A.; Hanson, J. E.; Whitesides, G. M.; Skehel, J. J.; Wiley, D. C. Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500 MHz proton nuclear magnetic resonance study Biochemistry 1989, 28, 8388-8396
25. Edwards, M. J.; Dimmock, N. J. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event J. Virol. 2001, 75, 10208-10218
26. Sui, J.; Hwang, W. C.; Perez, S.; Wei, G.; Aird, D.; Chen, L. M.; Santelli, E.; Stec, B.; Cadwell, G.; Ali, M.; Wan, H.; Murakami, A.; Yammanuru, A.; Han, T.; Cox, N. J.; Bankston, L. A.; Donis, R. O.; Liddington, R. C.; Marasco, W. A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses Nat. Struct. Mol. Biol. 2009, 16, 265-273
27. Taki, T.; Ishikawa, D.; Ogino, K.; Tanaka, M.; Oku, N.; Asai, T.; Popa, I.; Portoukalian, J. A new approach for drug discovery from glycobiology and phage-displayed peptide library technology Biochim. Biophys. Acta 2008, 1780, 497-503
28. Smith, G. P.; Petrenko, V. A. Phage Display Chem. Rev. 1997, 97, 391-410
29. Ladner, R. C.; Sato, A. K.; Gorzelany, J.; de Souza, M. Phage display-derived peptides as therapeutic alternatives to antibodies Drug Discovery Today 2004, 9, 525-529
30. Matsubara, T.; Ishikawa, D.; Taki, T.; Okahata, Y.; Sato, T. Selection of ganglioside GM1-binding peptides by using a phage library FEBS Lett. 1999, 456, 253-256
31. Smith, G. P.; Scott, J. K. Libraries of peptides and proteins displayed on filamentous phage Methods Enzymol. 1993, 217, 228-257
32. Noren, K. A.; Noren, C. J. Construction of high-complexity combinatorial phage display peptide libraries Methods 2001, 23, 169-178
33. Asahi, Y.; Yoshikawa, T.; Watanabe, I.; Iwasaki, T.; Hasegawa, H.; Sato, Y.; Shimada, S.; Nanno, M.; Matsuoka, Y.; Ohwaki, M.; Iwakura, Y.; Suzuki, Y.; Aizawa, C.; Sata, T.; Kurata, T.; Tamura, S. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines J. Immunol. 2002, 168, 2930-2938
34. Matsubara, T.; Hiura, Y.; Kawahito, O.; Yasuzawa, M.; Kawashiro, K. Selection of novel structural zinc sites from a random peptide library FEBS Lett. 2003, 555, 317-321
35. Taki, T.; Nishiwaki, S.; Ishii, K.; Handa, S. A simple and specific assay of glycosyltransferase and glycosidase activities by an enzyme-linked immunosorbent assay method and its application to assay of galactosyltransferase activity in sera from patients with cancer J. Biochem. 1990, 107, 493-498
36. Nishi, T.; Budde, R. J.; McMurray, J. S.; Obeyesekere, N. U.; Safdar, N.; Levin, V. A.; Saya, H. Tight-binding inhibitory sequences against pp60(c-src) identified using a random 15-amino-acid peptide library FEBS Lett. 1996, 399, 237-240
37. Yamanaka, K.; Ishihama, A.; Nagata, K. Reconstitution of influenza virus RNA-nucleoprotein complexes structurally resembling native viral ribonucleoprotein cores J. Biol. Chem. 1990, 265, 11151-11155
38. Sauter, N. K.; Hanson, J. E.; Glick, G. D.; Brown, J. H.; Crowther, R. L.; Park, S. J.; Skehel, J. J.; Wiley, D. C. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography Biochemistry 1992, 31, 9609-9621